To add yet another layer of complexity, in at least some AD models, while Trem2 haploinsufficiency appears to aggravate tau pathology in mice, complete Trem2 loss reportedly limits tau-driven microglial activation and atrophy48. The gene discussed is MAPT; the disease is Alzheimer disease.